Cabot (NYSE:CBT – Free Report) had its price target upped by JPMorgan Chase & Co. from $70.00 to $78.00 in a report released on Friday,Benzinga reports. They currently have an underweight rating on the specialty chemicals company’s stock. Other research analysts have also recently issued research reports about the stock. Truist Financial set a $100.00 […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00 | 0 | 13.04 | 10-08-2026 |
| 2 | Target (NYSE:TGT) Price Target Raised to $157.00 | 0 | 13.85 | 10-08-2026 |
| 3 | Maplebear (NASDAQ:CART) Price Target Raised to $62.00 | 0 | 13.46 | 10-08-2026 |
| 4 | Truist Financial Cuts Albemarle (NYSE:ALB) Price Target to $225.00 | 0 | 11.13 | 10-08-2026 |
| 5 | CACI International (NYSE:CACI) Price Target Raised to $715.00 | 0 | 14.65 | 10-08-2026 |
| 6 | Victory Capital (NASDAQ:VCTR) Price Target Raised to $101.00 | 0 | 11.9 | 10-08-2026 |
| 7 | JPMorgan Chase & Co. Cuts Zoetis (NYSE:ZTS) Price Target to $115.00 | 0 | 12.26 | 10-08-2026 |
| 8 | Cadre (NYSE:CDRE) Price Target Raised to $45.00 | 0 | 13.85 | 10-08-2026 |
| 9 | Genpact (NYSE:G) Price Target Raised to $45.00 | 0 | 14.26 | 10-08-2026 |
| 10 | Goodyear Tire & Rubber (NASDAQ:GT) Price Target Raised to $10.00 | 0 | 14.2 | 10-08-2026 |